Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
Christel BruggmannJuan F IglesiasMarianne Gex-FabryRachel FesseletPierre VogtFarshid SadeghipourPierre VoirolPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
The present study showed a high prescription rate of guideline-recommended medications in a referral center for primary percutaneous coronary intervention. At discharge, women and co-morbid patients were at the highest risk of incomplete prescription of guideline medications, whereas long-term prescription was suboptimal for elderly. A drug lacking at time of discharge was rarely introduced within the year, which underscores the paramount importance of optimal prescription at time of discharge. Strategies like implementing a standardized prescription could reduce the proportion of suboptimal prescription. It could therefore be one way to improve the long-term quality of care of our patients to the highest level. This study used local data from AMIS Plus-National Registry of Acute Myocardial Infarction in Switzerland (NCT01305785).
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- end stage renal disease
- acute myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- palliative care
- prognostic factors
- emergency department
- coronary artery disease
- primary care
- type diabetes
- st elevation myocardial infarction
- atrial fibrillation
- patient reported outcomes
- insulin resistance
- metabolic syndrome
- weight loss
- skeletal muscle
- middle aged
- deep learning
- community dwelling